Member Info for dactions

I don't think it's fair to criticize the government - despite the frustration all of us are feeling about this pandemic.

After the shock in late March when the scientists warned that older people were at risk just by virtue of their age, the Government made the political decision to protect them and the restrictions have got tighter as the scientists lowered the at risk age threshold to nearer 60. I only recall that there was 'hope' a vaccine could be produced by September and again there was only a 'hope' that a large quantity could be produced for use this year.

I want politicians to give me 'hope' so long as they believe it's possible - life is pretty miserable if you only have actual 'knowns' to go on. On balance, they're proving to be a darn sight closer to getting it right in this country than anywhere else right now. A good political call is they decision to eek out the Pfizer vaccine 2nd dose so more people can get a first dose. They're getting no thanks for making this call but it gives me 'hope' that I too will get a vaccine shot sooner rather than later.

Final point, I used to swear by all that channel 4 news and Jon Snow put out, but I've come to the realization that they take swipes at the government whichever way the latter might move - dammed if they do and dammed if they don't. Some of their so-called 'fact-checks' can be easily misinterpreted.

"They are now so focused on wood trading, they have excellent concessions, they look after their people and are known to be excellent in sustainability. If the SP can hold above 3p before year end, I reckon market sentiment for this share will improve considerably."

So, we've ended the year above 3p - I know it's only a small increase from the placing earlier in the year but I really think this auger's well for us. I'm hoping for a steady and sustained rise in the sp on the back of increased trading results. I'm sure that 2021 is going to be a turnaround year for Woodbois.

Good luck all.

BigDano - what an excellent thought and also getting the right link.
I hope it works out but you've certainly tried your best.

kdonkey1000 - I agree your explanation - in the absence of news sums up the situation FUM sp finds itself.

Odysseus07 - I don't see what purpose you achieve in trying to goad Ananda or any other BB contributor - you had quite a spat a few weeks back and all you achieve is selfishly spoil this BB for the rest of us.

In the last few days we've seen a modest but useful increase in the SP. As a LTH, the past 3 years have definitely been a disappointing ride and that's without COVID problems on top.

There was a large 1.1 million shares bought 22nd at 2.6p and today 24th there's been three large sales at 3p which could correspond to that buy. If it was that buy, that would have been a very nice £5k profit on a little over £28k put up short-term.

But I think there's a really good chance of a sustained recovery with this share, having watched the to and thros the past 10 years.

The lumbar market is really strong now and WBI has excellent concessions and their focus now on Gabon which is so much more stable than in other parts of Africa augers really well. Their cash position is now so much stronger than ever before including when they were known as Obtala with an almost Lonhro type of trading existence - too widespread, too many irons in the fire.

They are now so focused on wood trading, they have excellent concessions, they look after their people and are known to be excellent in sustainability. If the SP can hold above 3p before year end, I reckon market sentiment for this share will improve considerably.

I feel these third-party comments leading to small rallies are perhaps designed so others can off-load, or am I being cynical in this festive season of goodwill to man etc ?

I haven't subscribed to the TW 99p pep talks but have listened to Chris umpteen times over the past 10 years telling us next year it will be better. I think I paid as much as 25p a share many years ago. This is my worst performing share and other similar trading stories, I've cut successfully (meaning less losses !) but with Fox I've compounded my misery by adding yet more all the way down so haven't had your success TruroTrader.

I wish I had never heard of Fox Marble and Chris Gilbert - it's not just the money I've wasted but I feel Chris has abused my trust.

Have to admit to feeling really disappointed with RNS news from Falanx today - frankly it's not very inspiring. I'm still holding my shares as the sp could turn really quickly on some truly good sales news. However, my losses won't break the bank but I wonder just how much MD, Mike Read would stand to lose if they were to fold ?

Did anyone get to see the Woodbois presentation ?
Was it recorded do you know ?

Guys - we're looking for some grown-up discourse on this BB please

Good find J-CIT - this provides better reassurance than many of the posts we've seen so far. So there will be a future SNG !

So, CPT buys 'The Genome Store' which has been trading for less than a year - so there are no financials to see anywhere - it seems it operated via its Facebook page. It's central product is a Covid test for £95 a pop which they do via post with a hoped-for turnaround pre -3 days (but with no sales guarantee).

CPT has now changed its name to myhealthchecked plc - and the only product showing on its website is the Covid test. What has happened to the Concepta's myloworld.com ? Have we yet had any news of sales there and will it continue to trade separately ? Email sales queries and phone calls to its Web support number are not being answered ?

I'd like to see the sp rise as much as anyone, as I have horrible losses on this share, but the current setup doesn't look very professional and with very little shareholder information, the deal and the changes don't look good - just seem to want to quickly get on the Covid bandwagon before it's too late. I suppose at least no money is changing hands - just shares to be issued - but a whopping £520.000 worth of them.

yes - I agree that Prof Wilkinson said "imminent start to phase 3" and that starting this year dosing first patient - and that waiting on approvals to go ahead.

On this latter point - wasn't their mention at the time of the recent placing that they were waiting on approvals to start from the FDA ?

Re. Doc's point about keeping away from the BB - I too have decided this is the only way to keep one's sanity sometimes - unless you're trading the share. As a really LTH, I've kept my shares through thick and thin and just added and added - it's easy to see with hindsight where I could have traded - but I don't believe having sold I would have bought SNG again - so the eventual great gain I'm hoping for would have alluded me.

I am quite convinced my enlarged holding - even though my average sp is nowhere near as good as it once was - will do exceptionally well and we only have just a very few months to wait - mid Feb I reckon.

Good luck all.

Webinar recording will only be available to Full paid-up Sharesoc members, not free Associate members.

It was well attended (75+) - Richard Marsden wasn't quite as forthcoming as one hoped - this was partly down to spasmodic interruptions of his internet connection and some content and fluidity was lost as a consequence. The Phase III trial has not yet started but is still expected to start soon/this year. Although we know that it will spread to possibly 20 countries, nevertheless a heavy concentration will be on Hospital trials in this country because of SNG's status as Most Urgent by the UK quango - this will ensure earlier conclusion. That said, RM did indicate fastest could be 2 months to completion but could go to 5 months.

Home trials are still not completed and during the Summer months they had no participants but since October they are now coming in thick & fast. RM is aware that they have taken on new Home Trial participants from people introduced by investors. He would encourage this - anyone with early Covid symptoms over 65 but over 50 with comorbidities.

I'd hoped to hear news of the French Trials (Amiens ?) but RM said that was independent of SNG and had no news to impart.

The key financial point I took from this presentation was the likelihood that with positive data from Phase III that SNG would expect to sell to the Government (foreign governments too) for future Stockpiling. The product has excellent shelf life - 3 years in glass phials temp 2- 8 degrees and 5 years stored at -80 degrees. Assuming trials go well, the product will suit many respiratory diseases, not just Covid - hence the excitement towards income from governments stockpiling.

They are gearing up now for product on shelfs of 100,000 treatments per month (each comprising 14 sprays). RM said a reasonable value per treatment would be $3,000 similar to Remdesivir and so offers SNG massive income going forward.

At the end of the webinar when RM had left, there followed a good hour of back & forth discussion amongst investors/would-be ones. The consensus was that we have a good investment here with the Company clearly feeling positive but that Investors are finding the current shareprice journey perplexing and uncomfortable.

RM is open to questions from Investors - email him.

If it's Ahmet Dik - I think it's disappointing that we don't have details. Whoever it is, even at the current low price it's worth approx £10,000 - can't help but feel 'sour grapes' on my part.

Thanks Jakman - this is strong stuff for the BMJ implying widespread corruption - can it really be so bad as this ?

"When good science is suppressed by the medical-political complex, people die"
1st two paragraphs:
Politicians and governments are suppressing science. They do so in the public interest, they say, to accelerate availability of diagnostics and treatments. They do so to support innovation, to bring products to market at unprecedented speed. Both of these reasons are partly plausible; the greatest deceptions are founded in a grain of truth. But the underlying behaviour is troubling.
Science is being suppressed for political and financial gain. Covid-19 has unleashed state corruption on a grand scale, and it is harmful to public health.1 Politicians and industry are responsible for this opportunistic embezzlement. So too are scientists and health experts. The pandemic has revealed how the medical-political complex can be manipulated in an emergency—a time when it is even more important to safeguard science."

Thanks Monticello.

I see Prof. Tom Wilkinson is one of the presenters in a free 90 minutes webinar being hosted by the NIHR Monday 30th November - he'll be discussing the results from Synairgen's Phase 2 trial. here's the link:

https://ccf-nihr.zoom.us/webinar/register/WN_KZLwXfmUQaS3Cu0-UU48Zw

Yes agreed Graking . . . .
and side-benefit is you'll be with other savvy investors who'll have some interesting questions of their own for RM.

There's free access to the Share Society's webinar next Wednesday 18th November 5pm with Richard Marsden presenting Synairgen.

Questions can be forwarded ahead of time. You need to register as an Associate (which is free) - give your details/email etc why you're interested (ie to hear RM) and wait a day and they'll email you back with the invite. Totally free.

https://www.sharesoc.org/events/sharesoc-webinar-with-synairgen-sng-18-november-2020/

Sounds interesting presentation - have completed their form for the free 'Associate Member' which was required to book a place to RM's presentation 18th November but haven't seen any link to booking my place to the event. Has any one else managed to book their place ?

I totally agree Merchantman - I saw the midday fall around 120p and was stunned as I only saw Sng fall - in the absence of any worthwhile stock market comment turned on BBC news and saw news re vaccine.

I worked out sng was unchanged fundamentally- they still had £87 millions in the bank - they’re prospects of stage III success is still the same.

SO sold up other shares - took a loss on them and invested it all in more sng at 99p.

I’m locking them in with the others, again for the long term. It will come good. I have no doubts at all.